.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Citi
Baxter
QuintilesIMS
Express Scripts
Chubb
McKinsey
US Army
Covington
Cantor Fitzgerald

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091681

« Back to Dashboard
NDA 091681 describes DISULFIRAM , which is a drug marketed by Alvogen Malta and is included in one NDA. It is available from seven suppliers. Additional details are available on the DISULFIRAM profile page.

The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the disulfiram profile page.

Summary for NDA: 091681

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 091681

Suppliers and Packaging for NDA: 091681

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DISULFIRAM
disulfiram
TABLET;ORAL 091681 ANDA Alvogen Inc. 47781-607 47781-607-01 100 TABLET in 1 BOTTLE (47781-607-01)
DISULFIRAM
disulfiram
TABLET;ORAL 091681 ANDA Alvogen Inc. 47781-607 47781-607-30 30 TABLET in 1 BOTTLE, PLASTIC (47781-607-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Aug 8, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Mallinckrodt
Daiichi Sankyo
Colorcon
Fuji
Argus Health
Julphar
UBS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot